Terms: = Leukemia AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Prognosis
26 results:
1. Investigation of the function of the PI3-Kinase / AKT signaling pathway for leukemogenesis and therapy of acute childhood lymphoblastic leukemia (ALL).
Ehm P; Grottke A; Bettin B; Jücker M
Cell Signal; 2022 May; 93():110301. PubMed ID: 35259456
[TBL] [Abstract] [Full Text] [Related]
2. Inflammatory cytokine-regulated tRNA-derived fragment tRF-21 suppresses pancreatic ductal adenocarcinoma progression.
Pan L; Huang X; Liu ZX; Ye Y; Li R; Zhang J; Wu G; Bai R; Zhuang L; Wei L; Li M; Zheng Y; Su J; Deng J; Deng S; Zeng L; Zhang S; Wu C; Che X; Wang C; Chen R; Lin D; Zheng J
J Clin Invest; 2021 Nov; 131(22):. PubMed ID: 34779408
[TBL] [Abstract] [Full Text] [Related]
3. Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma.
Balakrishna J; Basumallik N; Matulonis R; Scott D; Salem D; Jasper G; Wiestner A; Stetler-Stevenson M; Marti G; Sun C; Yuan CM
Leuk Lymphoma; 2021 Aug; 62(8):1828-1839. PubMed ID: 33734005
[TBL] [Abstract] [Full Text] [Related]
4. [Clinical Analysis of Gene Mutation in Adult Patients with B-ALL and Its Influence on Clinical prognosis].
Deng M; Zuo WL; Zhang CL; Wei XD; Li XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1867-1872. PubMed ID: 33283712
[TBL] [Abstract] [Full Text] [Related]
5. Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantation.
Vasudevan Nampoothiri R; Chen S; Pasic I; Al-Shaibani Z; Lam W; Michelis FV; Kim DDH; Viswabandya A; Gerbitz A; Lipton JH; Kumar R; Mattsson J; Law AD
Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):134-140. PubMed ID: 33049225
[TBL] [Abstract] [Full Text] [Related]
6. Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up.
Paillassa J; Cornet E; Noel S; Tomowiak C; Lepretre S; Vaudaux S; Dupuis J; Devidas A; Joly B; Petitdidier-Lionnet C; Haiat S; Mariette C; Thieblemont C; Decaudin D; Validire-Charpy P; Drenou B; Eisenmann JC; Uribe MO; Olivrie A; Touati M; Lambotte O; Hermine O; Karsenti JM; Feugier P; Vaillant W; Gutnecht J; Lippert E; Huysman F; Ghomari K; Boubaya M; Levy V; Riou J; Damaj G; Tanguy-Schmidt A; Hunault-Berger M; Troussard X
Blood Cancer J; 2020 May; 10(5):62. PubMed ID: 32461544
[TBL] [Abstract] [Full Text] [Related]
7. Analysis of SNP Array Abnormalities in Patients with DE NOVO Acute Myeloid leukemia with Normal Karyotype.
Ibáñez M; Such E; Onecha E; Gómez-Seguí I; Liquori A; Sellés J; Hervás-Marín D; Barragán E; Ayala R; LLop M; López-Pavía M; Rapado I; Neef A; Sanjuan-Pla A; Sargas C; Gonzalez-Romero E; Boluda-Navarro M; Andreu R; Senent L; Montesinos P; Martínez-López J; Angel Sanz M; Sanz G; Cervera J
Sci Rep; 2020 Apr; 10(1):5904. PubMed ID: 32246042
[TBL] [Abstract] [Full Text] [Related]
8. akt2 mediates glucocorticoid resistance in lymphoid malignancies through FoxO3a/Bim axis and serves as a direct target for resistance reversal.
Xie M; Yang A; Ma J; Wu M; Xu H; Wu K; Jin Y; Xie Y
Cell Death Dis; 2019 Jan; 9(10):1013. PubMed ID: 30598523
[TBL] [Abstract] [Full Text] [Related]
9. Role of MSC-derived galectin 3 in the AML microenvironment.
Ruvolo PP; Ruvolo VR; Burks JK; Qiu Y; Wang RY; Shpall EJ; Mirandola L; Hail N; Zeng Z; McQueen T; Daver N; Post SM; Chiriva-Internati M; Kornblau SM; Andreeff M
Biochim Biophys Acta Mol Cell Res; 2018 Jul; 1865(7):959-969. PubMed ID: 29655803
[TBL] [Abstract] [Full Text] [Related]
10. [Analysis of prognosis of acute myeloid leukemia patients based on genetic mutations].
Shi J; Zhu Y; Hong M; Zhao H; Mao J; Jin H; Zhang W; Zhang T; Ma Y; Chen Y; Qian S; Li J; Qiao C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Dec; 34(6):806-811. PubMed ID: 29188605
[TBL] [Abstract] [Full Text] [Related]
11. Clinical significance of microRNAs in chronic and acute human leukemia.
Yeh CH; Moles R; Nicot C
Mol Cancer; 2016 May; 15(1):37. PubMed ID: 27179712
[TBL] [Abstract] [Full Text] [Related]
12. High constitutive akt2 activity in U937 promonocytes: effective reduction of akt2 phosphorylation by the histamine H2-receptor and the β2-adrenergic receptor.
Werner K; Neumann D; Seifert R
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jan; 389(1):87-101. PubMed ID: 26475619
[TBL] [Abstract] [Full Text] [Related]
13. prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia.
Pfirrmann M; Baccarani M; Saussele S; Guilhot J; Cervantes F; Ossenkoppele G; Hoffmann VS; Castagnetti F; Hasford J; Hehlmann R; Simonsson B
Leukemia; 2016 Jan; 30(1):48-56. PubMed ID: 26416462
[TBL] [Abstract] [Full Text] [Related]
14. Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults.
Cheng CL; Li CC; Hou HA; Fang WQ; Chang CH; Lin CT; Tang JL; Chou WC; Chen CY; Yao M; Huang SY; Ko BS; Wu SJ; Tsay W; Tien HF
BMC Cancer; 2015 May; 15():344. PubMed ID: 25934556
[TBL] [Abstract] [Full Text] [Related]
15. prognosis of patients with core binding factor acute myeloid leukemia after first relapse.
Kurosawa S; Miyawaki S; Yamaguchi T; Kanamori H; Sakura T; Moriuchi Y; Sano F; Kobayashi T; Yasumoto A; Hatanaka K; Yanada M; Nawa Y; Takeuchi J; Nakamura Y; Fujisawa S; Shibayama H; Miura I; Fukuda T
Haematologica; 2013 Oct; 98(10):1525-31. PubMed ID: 23716553
[TBL] [Abstract] [Full Text] [Related]
16. inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations.
Schwind S; Edwards CG; Nicolet D; Mrózek K; Maharry K; Wu YZ; Paschka P; Eisfeld AK; Hoellerbauer P; Becker H; Metzeler KH; Curfman J; Kohlschmidt J; Prior TW; Kolitz JE; Blum W; Pettenati MJ; Dal Cin P; Carroll AJ; Caligiuri MA; Larson RA; Volinia S; Marcucci G; Bloomfield CD;
Blood; 2013 Jan; 121(2):385-91. PubMed ID: 23160462
[TBL] [Abstract] [Full Text] [Related]
17. CD11b expression correlates with monosomal karyotype and predicts an extremely poor prognosis in cytogenetically unfavorable acute myeloid leukemia.
Chen MH; Atenafu E; Craddock KJ; Brandwein J; Chang H
Leuk Res; 2013 Feb; 37(2):122-8. PubMed ID: 23092917
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic significance of serum immunoglobulin paraprotein in patients with chronic lymphocytic leukemia.
Xu W; Wang YH; Fan L; Fang C; Zhu DX; Wang DM; Qiao C; Wu YJ; Li JY
Leuk Res; 2011 Aug; 35(8):1060-5. PubMed ID: 21208658
[TBL] [Abstract] [Full Text] [Related]
19. Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study.
Jinnai I; Sakura T; Tsuzuki M; Maeda Y; Usui N; Kato M; Okumura H; Kyo T; Ueda Y; Kishimoto Y; Yagasaki F; Tsuboi K; Horiike S; Takeuchi J; Iwanaga M; Miyazaki Y; Miyawaki S; Ohnishi K; Naoe T; Ohno R
Int J Hematol; 2010 Oct; 92(3):490-502. PubMed ID: 20830614
[TBL] [Abstract] [Full Text] [Related]
20. [The risk factors for thrombosis, myelofibrosis and leukemia transformation in patients with polycythemia vera].
Bai J; Xue YP; Ye L; Yao JF; Zhou CL; Qian LS; Yang RC; Li HY; Zhang HY; Shao ZH
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):685-8. PubMed ID: 18399175
[TBL] [Abstract] [Full Text] [Related]
[Next]
